Terms: = Breast cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
58 results:
1. Identifying Circulating Tumor DNA Mutations Associated with Neoadjuvant Chemotherapy Efficacy in Local Advanced breast cancer.
Wei B; Shan Y; Du Z; Yin C; Zhang Q; Lin H; Zhang G; Song D; Zuo H
Appl Biochem Biotechnol; 2022 Sep; 194(9):3961-3973. PubMed ID: 35579744
[TBL] [Abstract] [Full Text] [Related]
2. A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh.
Babu G; Bin Islam S; Khan MA
Mol Biol Rep; 2022 Jul; 49(7):6725-6739. PubMed ID: 35277785
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
[TBL] [Abstract] [Full Text] [Related]
4. Polymorphisms in genes involved in breast cancer among Iranian patients.
Farnoosh G; Saeedi-Boroujeni A; Jalali A; Keikhaei B; Mahmoudian-Sani MR
Per Med; 2021 Mar; 18(2):153-169. PubMed ID: 33565318
[TBL] [Abstract] [Full Text] [Related]
5. A33512C and Intronic Poly(AT) Insertion/Deletion (PAT-/+) Polymorphisms of the xpc Gene and Their Association With the Risk of breast cancer.
Qazvini MG; Salehi Z; Mashayekhi F; Saedi HS
Clin Breast Cancer; 2020 Dec; 20(6):e771-e777. PubMed ID: 32682659
[TBL] [Abstract] [Full Text] [Related]
6. xpc as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.
Malik SS; Zia A; Rashid S; Mubarik S; Masood N; Hussain M; Yasmin A; Bano R
Breast Cancer; 2020 Nov; 27(6):1168-1176. PubMed ID: 32562189
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive assessment of the association between xpc rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls.
Dai Y; Song Z; Zhang J; Gao W
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31710080
[TBL] [Abstract] [Full Text] [Related]
8. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer.
Jager M; Blokzijl F; Kuijk E; Bertl J; Vougioukalaki M; Janssen R; Besselink N; Boymans S; de Ligt J; Pedersen JS; Hoeijmakers J; Pothof J; van Boxtel R; Cuppen E
Genome Res; 2019 Jul; 29(7):1067-1077. PubMed ID: 31221724
[TBL] [Abstract] [Full Text] [Related]
9. DNA repair and apoptosis: Roles in radiotherapy-related acute reactions in breast cancer patients.
Batar B; Mutlu T; Bostanci M; Akin M; Tuncdemir M; Bese N; Guven M
Cell Mol Biol (Noisy-le-grand); 2018 Mar; 64(4):64-70. PubMed ID: 29631685
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Variations of DNA Repair Genes in breast cancer.
Özgöz A; Hekimler Öztürk K; Yükseltürk A; Şamlı H; Başkan Z; Mutlu İçduygu F; Bacaksız M
Pathol Oncol Res; 2019 Jan; 25(1):107-114. PubMed ID: 28983784
[TBL] [Abstract] [Full Text] [Related]
11. Fourier domain image fusion for differential X-ray phase-contrast breast imaging.
Coello E; Sperl JI; Bequé D; Benz T; Scherer K; Herzen J; Sztrókay-Gaul A; Hellerhoff K; Pfeiffer F; Cozzini C; Grandl S
Eur J Radiol; 2017 Apr; 89():27-32. PubMed ID: 28267545
[TBL] [Abstract] [Full Text] [Related]
12. Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung cancer.
Jia L; Yan F; Cao W; Chen Z; Zheng H; Li H; Pan Y; Narula N; Ren X; Li H; Zhou P
J Biol Chem; 2017 Feb; 292(7):2966-2978. PubMed ID: 27974468
[TBL] [Abstract] [Full Text] [Related]
13. Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population.
He BS; Xu T; Pan YQ; Wang HJ; Cho WC; Lin K; Sun HL; Gao TY; Wang SK
Oncotarget; 2016 Dec; 7(51):84872-84882. PubMed ID: 27768589
[TBL] [Abstract] [Full Text] [Related]
14. Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers.
Domagala P; Hybiak J; Rys J; Byrski T; Cybulski C; Lubinski J
Oncotarget; 2016 Oct; 7(42):68662-68673. PubMed ID: 27626685
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of DNA Repair Genes Polymorphisms in breast cancer.
Romanowicz H; Pyziak Ł; Jabłoński F; Bryś M; Forma E; Smolarz B
Pathol Oncol Res; 2017 Jan; 23(1):117-123. PubMed ID: 27571987
[TBL] [Abstract] [Full Text] [Related]
16. DNA Repair Gene Expression Levels as Indicators of breast cancer in the breast cancer Family Registry.
Kappil MA; Liao Y; Terry MB; Santella RM
Anticancer Res; 2016 Aug; 36(8):4039-44. PubMed ID: 27466510
[TBL] [Abstract] [Full Text] [Related]
17. Genetic Evidence for xpc-KRAS Interactions During Lung cancer Development.
Zhang X; He N; Gu D; Wickliffe J; Salazar J; Boldogh I; Xie J
J Genet Genomics; 2015 Oct; 42(10):589-596. PubMed ID: 26554912
[TBL] [Abstract] [Full Text] [Related]
18. Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.
Kap EJ; Seibold P; Richter S; Scherer D; Habermann N; Balavarca Y; Jansen L; Becker N; Pfütze K; Popanda O; Hoffmeister M; Ulrich A; Benner A; Ulrich CM; Burwinkel B; Brenner H; Chang-Claude J
Pharmacogenomics J; 2015 Dec; 15(6):505-12. PubMed ID: 25778469
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of gene regulatory networks of benign and malignant breast cancer samples with normal samples.
Chen DB; Yang HJ
Genet Mol Res; 2014 Nov; 13(4):9453-62. PubMed ID: 25501155
[TBL] [Abstract] [Full Text] [Related]
20. Combined genetic and nutritional risk models of triple negative breast cancer.
Lee E; Levine EA; Franco VI; Allen GO; Gong F; Zhang Y; Hu JJ
Nutr Cancer; 2014; 66(6):955-63. PubMed ID: 25023197
[TBL] [Abstract] [Full Text] [Related]
[Next]
